Carcinoma in Dogs: Types, Treatment, and the Real Role of Rapamycin

Short answer: a carcinoma is a cancer that starts in epithelial tissue — the cells that line skin, glands and organs. Carcinomas in dogs are treated by veterinary oncologists with surgery, and sometimes chemotherapy or radiation, depending on the type and stage. Rapamycin is not an established treatment for carcinoma in dogs; its studied role is canine aging, not oncology.

What "carcinoma" means

Cancers are named partly by the tissue they arise from. A carcinoma starts in epithelial cells — the linings of skin, glands and internal organs. That is different from a sarcoma (from connective tissue like bone or muscle) or lymphoma (from immune cells). The distinction matters because it shapes how the cancer behaves and how it is treated.

Common carcinomas in dogs

• Squamous cell carcinoma — skin, mouth, toes.
• Mammary carcinoma — common in unspayed females.
• Transitional cell carcinoma — bladder and urinary tract.
• Thyroid and lung carcinomas — internal, often found later.

Each has its own outlook, which is why staging by a veterinarian comes before any treatment decision.

How carcinomas are treated

The tools with real evidence are surgery (often the mainstay, especially when the tumour is localised), radiation (for tumours that are hard to remove completely), and chemotherapy (when the cancer has spread or carries a high risk of spreading). A veterinary oncologist matches the approach to the specific carcinoma and stage. This is the part of the story with the strongest evidence — and it is where an owner’s energy should go first.

The real role of rapamycin

It is fair to ask whether an mTOR inhibitor like rapamycin adds anything. The honest answer, from the evidence: not as a carcinoma treatment. mTOR is a legitimate cancer target and rapamycin reaches it in canine tumours, but the pivotal canine trial in osteosarcoma showed no survival benefit, and there is no trial showing it treats carcinomas. Reviews of repurposed drugs in canine oncology place mTOR inhibitors firmly in the investigational column (Giuliano et al., Animals 2022).

Where rapamycin is studied is canine healthy aging — a separate goal, in healthy dogs, under veterinary direction. Conflating the two is exactly the mistake to avoid.

Rapamycin is not a cancer treatment. If your dog has been diagnosed with cancer, a veterinary oncologist is the right first call. If you have a healthy older dog and want to understand veterinarian-directed longevity care, talk to the Rapavie team on WhatsApp — we will tell you honestly whether it makes sense for your dog.